Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1106072 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interleukin 13 Receptor, alpha 2 (IL13RA2) antibody
- Antibody type
- Monoclonal
- Description
- Ion Exchange Chromatography.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- B-D13
- Vial size
- 0.2 mg
- Storage
- Store the antibody undiluted at 2-8°C.
Submitted references Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors.
IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis.
Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease.
Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin.
Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells.
IL-13 receptor-targeted cytotoxin cancer therapy leads to complete eradication of tumors with the aid of phagocytic cells in nude mice model of human cancer.
Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas.
Kawakami K, Terabe M, Kioi M, Berzofsky JA, Puri RK
Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Aug 1;12(15):4678-86
Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Aug 1;12(15):4678-86
IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis.
Blanchard C, Durual S, Estienne M, Bouzakri K, Heim MH, Blin N, Cuber JC
Journal of immunology (Baltimore, Md. : 1950) 2004 Mar 15;172(6):3775-83
Journal of immunology (Baltimore, Md. : 1950) 2004 Mar 15;172(6):3775-83
Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease.
Kawakami K, Kawakami M, Puri RK
Molecular cancer therapeutics 2004 Feb;3(2):137-47
Molecular cancer therapeutics 2004 Feb;3(2):137-47
Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
Kawakami M, Kawakami K, Kasperbauer JL, Hinkley LL, Tsukuda M, Strome SE, Puri RK
Clinical cancer research : an official journal of the American Association for Cancer Research 2003 Dec 15;9(17):6381-8
Clinical cancer research : an official journal of the American Association for Cancer Research 2003 Dec 15;9(17):6381-8
Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin.
Joshi BH, Kawakami K, Leland P, Puri RK
Clinical cancer research : an official journal of the American Association for Cancer Research 2002 Jun;8(6):1948-56
Clinical cancer research : an official journal of the American Association for Cancer Research 2002 Jun;8(6):1948-56
Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells.
Lordan JL, Bucchieri F, Richter A, Konstantinidis A, Holloway JW, Thornber M, Puddicombe SM, Buchanan D, Wilson SJ, Djukanović R, Holgate ST, Davies DE
Journal of immunology (Baltimore, Md. : 1950) 2002 Jul 1;169(1):407-14
Journal of immunology (Baltimore, Md. : 1950) 2002 Jul 1;169(1):407-14
IL-13 receptor-targeted cytotoxin cancer therapy leads to complete eradication of tumors with the aid of phagocytic cells in nude mice model of human cancer.
Kawakami K, Kawakami M, Puri RK
Journal of immunology (Baltimore, Md. : 1950) 2002 Dec 15;169(12):7119-26
Journal of immunology (Baltimore, Md. : 1950) 2002 Dec 15;169(12):7119-26
Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas.
Joshi BH, Plautz GE, Puri RK
Cancer research 2000 Mar 1;60(5):1168-72
Cancer research 2000 Mar 1;60(5):1168-72
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS